|
|
Clinicians often have questions about referring patients to Cleveland Clinic for adult congenital heart disease. Dr. Margaret Fuchs answers the following questions:
Are there guidelines and…
|
|
|
New primary prevention guidelines for women addresses both risk factors unique to women, such as auto-immune disease and pregnancy related factors, as well as differences in traditional risk factors…
|
|
|
Thursday, March 12, 2020
7:00 a.m. – 8:00 a.m. EST
Case Presentations:
Update on COVID-19 and what it means for our patients (CCF Main)
|
|
|
Dr. Steven Nissen, Chief Academic Officer, Sydell and Arnold Miller Family Heart, Vascular and Thoracic Institute talks with Dr. Serg Harb, a staff imaging cardiologist about the innovative…
|
|
|
Dr. Venu Menon, Director of the Cardiovascular Fellowship Program and Section Head, Clinical Cardiology talks with Eoin Donnellen MD, a third year cardiovascular fellow about the impact of…
|
|
|
Dr. Steven Nissen, Chief Academic Officer, Sydell and Arnold Miller Family Heart & Vascular Institute talks with Dr. Leslie Cho, Section Head Preventive Cardiology & Rehabilitation about…
|
|
|
Dr. Steven Nissen, Chief Academic Officer, Chief Academic Officer, Sydell and Arnold Miller Family Heart & Vascular Institute talks about cardiomyopathy with Wilson Tang, MD, Director of…
|
|
|
Dr. Rick Grimm, Director of the Echocardiography Laboratory and Helga Lombardo RDCS, FASE Supervisor, Echocardiography Lab discuss many aspects of running a successful high volume echo lab.
Dr.…
|
|
|
Dr. Leslie Cho, Section Head, Preventive Cardiology and Rehabilitation and Director of Women’s Cardiovascular Center discusses tips for health care providers in treating statin intolerance. She…
|
|
|
Dr. Erik Van Iterson, Director of Cardiac Rehabilitation at Cleveland Clinic describes the benefits of cardiac rehabilitation for various patient populations, current enrollment statistics, factors…
|
|
|
Dr. Luke Laffin, staff cardiologist in Preventive Cardiology and Clinical Specialist in Hypertension at Cleveland Clinic answers questions that patients often ask about taking high blood pressure…
|
|
|
Dr. Stephen Ellis summarizes the discussions surrounding bioabsorbable scaffolding or stents: why they were hypothesized, the results of the trials; and where we are now.
|
|
|
Dr. Steve Nissen discusses the results of three important late breaking trials looking at the impact of three drugs on cardiovascular endpoints: the CANTOS trial (Canakinumab); the REVEAL study…
|
|
|
Dr. Stephen Ellis discusses the results of recent trials at ACC related to Instantaneous Wave-Free Ration (iFR) and how the results impact practice in the cath lab.
|
|
|
Dr. Stephen Ellis discusses the results of recent bioresorbable stent trials including the ABSORB III trial and what the results mean for clinical practice.
|